This article might have been posted here originally:
"Next to fibres, shivs and seeds, this year a new topic arises: Cannabidiol (CBD), a by-product from industrial hemp, shows high therapeutic and financial potential without any relevant side effects."
"Many scientists, companies and farmers show increasing interest in the medicinal and financial value of this cannabinoid. A few numbers will show why CBD is so interesting and inspires the imagination of investors and farmers: As a by-product of industrial hemp cultivated for fibres or seeds, around 3 kg CBD per ha can be extracted from flowers, leaves and stems. The market price of pharmaceutical CBD today is between 20,000 and 30,000 €/kg. Also with relevant harvesting, drying and extraction costs, there is potential for an attractive extra profit for the farmers."